We have received another tranche of funds from a German investor. This is an effect of the agreement signed on 10 July with a German fund, Deutsche Balaton AG. The funds obtained will be used to introduce our solution: Pregnabit teleCTG to new foreign markets.
“We have great faith in Nestmedic and its product. In our opinion, it fills a gap in the medical sector on many markets. We hope to connect well with the Nestmedic team and be globally successful together,” said Armin Burckhardt, Equity Manager, Deutsche Balaton AG.
The transaction between Nestmedic S.A. and Deutsche Balaton AG concerned the issue of bonds convertible into series A shares under a private placement arrangement. All 28,571 series A bonds at the price of 150 PLN per one series A bond have been offered to Deutsche Balaton AG as a shareholder. The transaction amounted to the total of 4,282,560 PLN.
“We are very happy to close another stage of our cooperation with Deutsche Balaton AG. The transaction is a tangible proof that the Company and its market prospects are something to be trusted and confided in. The financing is the source of stability and the opportunity to focus more strongly on the actual business expansion. We also want to use the international experience and contacts of Deutsche Balaton AG,” emphasizes Konrad Kowalczuk, Member of the Management Board of Nestmedic S.A.